These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9013476)

  • 1. Detection of minimal residual disease in multiple myeloma and acute leukaemia.
    Bakkus MH; Juge-Morineau N; van der Werff ten Bosch JE
    Med Oncol; 1996 Jun; 13(2):121-31. PubMed ID: 9013476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of minimal residual disease.
    Deptala A; Mayer SP
    Methods Cell Biol; 2001; 64():385-420. PubMed ID: 11070849
    [No Abstract]   [Full Text] [Related]  

  • 3. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of minimal residual disease in autologous bone marrow transplantation].
    Jørgensen H; Bukh A; Hokland P; Ellegaard J; Madsen PS; Hokland M
    Nord Med; 1996 Dec; 111(10):344-7. PubMed ID: 8992466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular methods for detection of minimal residual disease following transplantation in lymphoid and plasma cell disorders.
    Corradini P; Carniti C
    Methods Mol Biol; 2014; 1109():209-37. PubMed ID: 24473786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of minimal residual disease in patients with acute leukemia.
    Baer MR
    Curr Opin Oncol; 1998 Jan; 10(1):17-22. PubMed ID: 9466480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease monitoring in multiple myeloma.
    Davies FE; Rawstron AC; Owen RG; Morgan GJ
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):197-222. PubMed ID: 11987924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.
    McAuliffe S; Brown R; Catalano A; Ho PJ; Nassif N; Woodland N; Hart D; Weatherburn C; Yang S; Suen H; Paul C; Joshua D; Gibson J
    Leuk Lymphoma; 2015; 56(9):2714-6. PubMed ID: 25651422
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma.
    Ladetto M; Donovan JW; Harig S; Trojan A; Poor C; Schlossnan R; Anderson KC; Gribben JG
    Biol Blood Marrow Transplant; 2000; 6(3):241-53. PubMed ID: 10871149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of minimal residual disease in multiple myeloma.
    Bai Y; Orfao A; Chim CS
    Br J Haematol; 2018 Apr; 181(1):11-26. PubMed ID: 29265356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay.
    Rasmussen T; Poulsen TS; Honoré L; Johnsen HE
    Exp Hematol; 2000 Sep; 28(9):1039-45. PubMed ID: 11008016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients.
    Powles R; Sirohi B; Kulkarni S; Bhagwati N; Saso R; Raje N; Horton C; Singhal S; Mehta J; Treleaven J
    Bone Marrow Transplant; 2000 May; 25(9):949-56. PubMed ID: 10800062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in leukaemia patients.
    Szczepański T; Orfão A; van der Velden VH; San Miguel JF; van Dongen JJ
    Lancet Oncol; 2001 Jul; 2(7):409-17. PubMed ID: 11905735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
    Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
    Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.
    Martinez-Lopez J; Martinez-Sanchez P; Garcia-Sanz R; Sarasquete ME; Ayala R; Gonzalez M; Bautista JM; Gonzalez D; San Miguel J; Garcia-Effron G; Lahuerta JJ
    J Mol Diagn; 2006 Jul; 8(3):364-70. PubMed ID: 16825510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease detection in myeloma: no more molecular remissions?
    Rawstron AC
    Haematologica; 2005 Oct; 90(10):1300B. PubMed ID: 16219557
    [No Abstract]   [Full Text] [Related]  

  • 18. Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.
    Fenk R; Ak M; Kobbe G; Steidl U; Arnold C; Korthals M; Hünerlitürkoglu A; Rohr UP; Kliszewski S; Bernhardt A; Haas R; Kronenwett R
    Haematologica; 2004 May; 89(5):557-66. PubMed ID: 15136219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myeloma.
    Compagno M; Mantoan B; Astolfi M; Boccadoro M; Ladetto M
    Methods Mol Med; 2005; 113():145-63. PubMed ID: 15968100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
    Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
    Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.